Law Firm Promotes Corcept Therapeutics Incorporated

The Law Offices of Howard G. Smith is urging shareholders of Corcept Therapeutics Incorporated (CORT) to investigate potential securities fraud in connection with the company. The law firm is seeking shareholders who have suffered losses as a result of alleged misrepresentations by Corcept Therapeutics and its executives.

Corcept Therapeutics is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of severe metabolic, psychiatric, and oncologic disorders. The company’s lead product, Korlym, is designed to treat patients with Cushing’s syndrome, a rare endocrine disorder.

The allegations against Corcept Therapeutics stem from a class action lawsuit that was filed on behalf of investors who purchased the company’s securities between May 2, 2017, and February 5, 2021. The lawsuit claims that Corcept and its executives made false and misleading statements about the efficacy and potential of Korlym, as well as the company’s compliance with regulatory requirements.

Specifically, the lawsuit alleges that Corcept misled investors about the success of Korlym in treating Cushing’s syndrome and failed to disclose adverse events associated with the drug. Additionally, the lawsuit claims that Corcept engaged in improper marketing practices that violated federal laws and regulations.

As a result of these alleged misrepresentations, the lawsuit claims that Corcept’s stock price was artificially inflated during the class period. When the truth about the company’s practices and the efficacy of Korlym came to light, the stock price plummeted, causing significant financial harm to investors.

The Law Offices of Howard G. Smith is encouraging shareholders who have suffered losses in connection with Corcept Therapeutics to contact the firm to discuss their legal rights. Shareholders may be able to recover their losses through participation in the class action lawsuit or other legal avenues.

If you are a shareholder of Corcept Therapeutics and have questions about your legal rights or potential claims, do not hesitate to reach out to the Law Offices of Howard G. Smith. The firm has a track record of success in securities litigation and is committed to holding companies accountable for fraudulent practices that harm investors. Contact the firm today to learn more about your options.